ロード中...
Pertuzumab and trastuzumab: the rationale way to synergy
It has now been 15 years since the HER2-targeted monoclonal antibody trastuzumab was introduced in clinical and revolutionized the treatment of HER2-positive breast cancer patients. Despite this achievement, most patients with HER2-positive metastatic breast cancer...
保存先:
| 出版年: | Anais da Academia Brasileira de Ciências |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Academia Brasileira de Ciências
2016
|
| 主題: | |
| オンライン・アクセス: | https://www.redalyc.org/articulo.oa?id=32746362012 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|